Form 4: Atlas Venture Fund XI Distributes Third Harmonic Bio Shares Pro Rata

Sentiment:

SEC Form 4 Filing


Atlas Venture Fund XI distributed 515,688 shares of Third Harmonic Bio to its partners on November 1, 2024, as part of a pre-arranged plan.

Summary

  • Atlas Venture Fund XI, L.P. distributed 515,688 shares of Third Harmonic Bio, Inc. common stock.
  • The distribution was pro rata to its general partner and limited partners.
  • The transaction occurred on November 1, 2024.
  • The shares were disposed of at a price of $0 per share as it was a distribution, not a sale.
  • Following the transaction, Atlas Venture Fund XI, L.P. beneficially owns 9,798,075 shares of Third Harmonic Bio, Inc.
  • The distribution was executed under a Rule 10b5-1 plan adopted on September 26, 2024.

Sentiment

Score: 6

Explanation: The document describes a routine distribution of shares, which is neither particularly positive nor negative. The distribution was pre-planned and doesn't indicate a change in the fund's overall view of the company.

Industry Context

Venture capital funds often distribute shares of portfolio companies to their limited partners as part of the fund's lifecycle. This allows the partners to manage their own positions in the company.

Related Party Transactions

  • The distribution of shares to the general partner and limited partners of Atlas Venture Fund XI constitutes a related party transaction.

Stakeholder Impact

  • The distribution may have a minor impact on the trading volume of Third Harmonic Bio shares as the recipients may choose to sell their newly distributed shares.

Key Dates

DateDescription
September 26, 2024Date of adoption of Rule 10b5-1 plan by Atlas Venture Fund XI.
November 01, 2024Date of pro rata distribution of Third Harmonic Bio shares.
November 05, 2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.